1100 CAMPUS ROAD, PRINCETON, NJ
Financial Results, Press Release
Integra LifeSciences Adopts Change in Control Severance Program
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
News, Material Contracts
Reports First Quarter 2025 Financial Results
Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
FY 2024
Q3
Q2
Q1
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report